Of note, there is considerable evidence that both IGF1R and EGFR crosstalk in BC cells and their coactivation occurs in approximately 25% of BC, related with poor outcome (Harris et al, 2001, 2007; Lu et al, 2001; Abd El-Rehim et al, 2004). The gene discussed is IGF1R; the disease is breast cancer.